Heart screen could protect hundreds from stroke
Testing Māori and Pacific people for an irregular heartbeat earlier could spare hundreds of people from stroke each year, a University of Auckland study has found.
Global media interest in HRI’s breakthrough anti-clotting drug for COVID-19
The revolutionary new anti-clotting medicine developed by HRI has attracted global media interest due to its far-reaching impact.
HRI researchers on cusp of worldwide breakthrough in COVID-19 treatment
Researchers at HRI believe they may hold the key to controlling the deadly blood clots caused by COVID-19.
Why our hearts fail
Scientists at HRI and The University of Sydney have made new heart failure discoveries in an innovative world-first project examining cryo-preserved human hearts.
HRI announces novel anti-clotting drug to help critically ill COVID-19 patients
HRI is on the precipice of a significant research breakthrough for the treatment of one of the major life-threatening complications of the novel coronavirus (COVID-19), microscopic blood clots.
Cardiovascular Medical Devices Group reviews next-generation surfaces
HRI's Cardiovascular Medical Devices Group reviews next-generation liquid-infused surfaces that could be used to improve medical devices like heart bypass machines.
HRI undertakes critical research into COVID-19-related heart disease
The Heart Research Institute, in partnership with major NSW hospitals, universities, and other research institutions, is striving to unravel the deadly link between the coronavirus (COVID-19) and cardiovascular disease.
Revealed: The molecule messing with your gym workout
Research by HRI explains why some people fail to shed pounds and lower cholesterol even when eating well and exercising hard.
World-leading researcher in atherosclerosis to join HRI
World-leading researcher in atherosclerosis, Dr Tessa Barrett, will lead a new research group at HRI, funded by a prestigious NSW Cardiovascular Elite Postdoctoral Researcher Grant from NSW Health and HRI’s Robert Edward Gough Fellowship.